RankAlpha logo
Back to Rankings

GYRE

Gyre TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
GYRE vs peer average
70/100
GYRE vs. peer average (B vs. C)
Grade spread
A 1 · B 4 · C 1 · D 1 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ALT is the first available peer comparator.

Loose same-sector small-cap biopharma comp for event-driven trading and regulatory optionality; useful for sentiment framing, not a direct operating analog.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerALTAltimmune
GYRE
Gyre Therapeutics
ALT
Altimmune
Grade
B
F
Momentum
61
15
Value
58
41
Sentiment
54
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs ALT

GYRE / ALT
Grade Position
Above peers
GYRE vs. peer average (B vs. C)
70/100
Momentum
61
GYRE
Value
58
GYRE
Sentiment
54
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs GYRE
1
ALT
ALT
F
20/100
+3
2
ARVN
ARVN
B
80/100
Even
3
CBIO
CBIO
D
40/100
+2
4
STTK
Shattuck Labs Inc Common
B
80/100
Even
5
FTH
Faeth Therapeutics Inc Common
A
100/100
-1
ALT is the first peer returned for this comparison set.